Turk Ilac ve Serum Sanayi AS (TRILC) — Capital Reinvestment Ratio
Turk Ilac ve Serum Sanayi AS (TRILC) has a Capital Reinvestment Ratio of 3.20x as of September 2025, meaning it reinvests 3% of its operating cash flow (TL44.50 Million) in capital expenditures (TL142.42 Million). Check TRILC tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Turk Ilac ve Serum Sanayi AS Capital Reinvestment Ratio (2019–2023)
This chart tracks Turk Ilac ve Serum Sanayi AS's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Turk Ilac ve Serum Sanayi AS.
Annual Capital Reinvestment Ratio for Turk Ilac ve Serum Sanayi AS (2019–2023)
Year-by-year Capital Reinvestment Ratio for Turk Ilac ve Serum Sanayi AS from 2019 to 2023. See how much free cash does Turk Ilac ve Serum Sanayi AS generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (TRY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.28x | TL408.19 Million | TL115.31 Million | ▼ -43.3% |
| 2020 | 0.50x | TL33.20 Million | TL16.54 Million | ▼ -73.4% |
| 2019 | 1.87x | TL13.32 Million | TL24.92 Million | — |